TABLE 1.
HIV-1 Infected (n = 25) |
Uninfected Control (n = 44) |
|
---|---|---|
Male sex, n (%) | 19 (76) | 21 (48) |
Median age, n (range) | 50 (31–71) | 27 (21–60) |
BMI, n (range) | 23.5 (18.9–43.5) | 23.6 (18–32.9) |
Race, n (%) | ||
White | 11 (44) | 25, (57) |
Black | 13 (52) | 1 (2) |
Asian | 0 (0) | 15 (34) |
Other | 1 (4) | 3 (7) |
Ethnicity, n (%) | ||
Hispanic | 11 (44) | 3 (7) |
Non-Hispanic | 14 (56) | 41 (93) |
Smoking status | ||
Current smoker | 14 (56) | 2 (5.7) |
Mean years since HIV-1 diagnosis, n (range) |
9.5 (1–26) | N/A |
Mean years of effective ART, n (range) |
6 (0.5–21) | N/A |
Mean CD4 count, n (range) | 630 (181–1124) | N/A |
Mean CD4 nadir, n (range) | 166 (5–422) | N/A |
Current antiretroviral usage | 9 NNRTI based | N/A |
13 PI based | — | |
4 Raltegravir based |
||
5 Abacavir containing |